Tokyo, Feb. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060572) titled 'A study examining recovery and outcomes after surgery for spinal and spinal cord conditions' on Feb. 10.

Study Type: Observational

Primary Sponsor: Institute - Japan Community Healthcare Organization Osaka Hospital

Condition: Condition - Degenerative spinal diseases Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to prospectively collect and analyze clinical courses and imaging data from patients undergoing surgery for degenerative spinal diseases, in order to identify factors influencing surgical outcomes and to generate evidence that contributes to the safe and effective practice of spine surgery. Basic objectives2 - Safety,Efficacy

Eligibility: Age-lower limit - Not applicable Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - All patients who undergo surgical treatment for spinal or spinal cord diseases at our institution between 2026 and 2030 as part of standard clinical practice.

Eligible conditions include degenerative spinal diseases (such as myelopathy, intervertebral disc herniation, spinal canal stenosis, and ossification of spinal ligaments) as well as spinal deformities (including adult spinal deformity and idiopathic scoliosis). Surgical procedures include decompression surgery, fusion surgery, and deformity correction surgery, and eligibility is not restricted by the type of surgical procedure. Key exclusion criteria - In principle, no exclusion criteria will be applied. Target Size - 2500

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 01 Month 08 Day Date of IRB - 2026 Year 01 Month 28 Day Anticipated trial start date - 2026 Year 01 Month 28 Day Last follow-up date - 2030 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069218

Disclaimer: Curated by HT Syndication.